TNFAIP8 deficiency exacerbates acute graft versus host disease in a murine model of allogeneic hematopoietic cell transplantation.
Gastrointestinal acute graft-versus-host disease (aGVHD) occurring after allogeneic hematopoietic cell transplant (allo-HCT) is an alloreactive T cell- and inflammatory cytokine driven organ injury with epithelial apoptosis as one of its hallmark findings, and is associated with significant mortality. Tumor necrosis factor (TNF)-alpha-induced protein 8 (TNFAIP8 or TIPE) acts as a negative mediator of apoptosis via inhibition of caspase-3 activation, promotes cell proliferation and Tipe deficiency is associated with increased inflammation. To evaluate the role of TIPE in acute GVHD, naive C57BL/6 and Tipe C57BL/6 mice were conditioned with 1000cGy single dose total-body irradiation, followed by transplantation of 10 million bone marrow (BM) cells and 20 million splenocytes from either syngeneic C57BL/6 or allogeneic BALB/c donors. Allo TIPE-deficient mice developed exacerbated gut GVHD compared to allo controls and had significantly decreased survival (6 weeks OS: 85% vs 37%; p<0.05), higher clinical GVHD scores, more profound weight loss, increased serum proinflammatory cytokines (IL-17A, TNF, IL-6, IFN-y). T cell infiltration into the ileum was increased; epithelial proliferation was decreased along with significantly higher levels of chemokines KC and MIG. Using BM chimeric experiments, TIPE was found to have a role in both hematopoietic and nonhematopoietic cells. Absence of TIPE results in excessive inflammation and tissue injury after allo HCT, supporting that TIPE confers immune homeostasis and has tissue-protective function during the development of gut GVHD, and may be a potential future target to prevent or treat this complication after allogeneic HCT.